← All Hims & Hers Health, INC filings

Hims & Hers Health, INC 8-K filings

NYSE
HIMS
Hims & Hers Health, INC
8-K: Hims & Hers Health Expands Board with Appointment of Christopher Payne
Hims & Hers Health, Inc. has increased its board size and appointed Christopher Payne as a new independent director, effective March 30, 2024.
NYSE
HIMS
Hims & Hers Health, INC
8-K: Hims & Hers Health Inc. Reports Strong 2023 Results, Achieves Profitability and Provides Optimistic 2024 Guidance
Hims & Hers Health, Inc. announced a 65% year-over-year revenue increase for 2023, achieving net income profitability in Q4 and providing strong guidance for 2024.